Article

pacbiztimes.com on 2020-01-03 01:54

Amgen’s $2.8 billion deal to acquire stake in BeiGene closes

Amgen's deal to acquire a minority stake in Chinese oncology research firm BeiGene closed Jan. 2, with a $2.8 billion cash price tag.

Related news